| Literature DB >> 7526972 |
N Shinoura1, S C Heffelfinger, M Miller, O I Shamraj, N H Miura, J J Larson, N DeTribolet, R E Warnick, J J Tew, A G Menon.
Abstract
The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CRP expression might play a role in the malignant progression of these tumors. The benign and atypical meningiomas, and the astrocytomas showed high expression of SP-40,40, low expression of CD59, and barely detectable expression of CD46, CD55 and S-protein. The benign and atypical menigiomas showed significantly greater expression of SP-40,40 at the RNA level when compared to malignant meningiomas. This study describes the mRNA expression of meningiomas, astrocytomas, tumor cell lines and normal human tissues.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7526972 DOI: 10.1016/0304-3835(94)90072-8
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679